ADMA BIOLOGICS, INC.

Unless the context otherwise requires, references in this Business section to ADMA, ADMA Biologics, the Company, we, us and our refer to ADMA Biologics, Inc., a Delaware corporation, as well as its wholly owned subsidiaries, ADMA BioManufacturing, LLC, a Delaware limited liability company ( ADMA BioManufacturing ), ADMA BioCenters Georgia Inc., a Delaware corporation ( ADMA BioCenters ) and ADMA Plasma Biologics, Inc., a Delaware corporation ( ADMA Plasma Biologics ). Overview We are a U.S. based end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Our targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. Through our ADMA BioManufacturing business segment, we currently have three products with U.S.